Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2009 Sep;3(5):208-11.

Five-year survival of metastatic pancreatic carcinoma: a study of courage and hope

Ben M Chue  1
Affiliations
Case Reports

Five-year survival of metastatic pancreatic carcinoma: a study of courage and hope

Ben M Chue. Gastrointest Cancer Res. 2009 Sep.

Erratum in

  • Errata.
    [No authors listed] [No authors listed] Gastrointest Cancer Res. 2009 Nov;3(6):258. Gastrointest Cancer Res. 2009. PMID: 21151432 Free PMC article.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Original biopsy specimens of the metastatic liver lesion. Analysis revealed metastatic adenocarcinoma, most likely from a pancreatic primary.
Figure 2.
Figure 2.
Baseline computed tomography (CT) images from January 2005 showing a large mass at the tail of the pancreas and extensive liver metastases.
Figure 3.
Figure 3.
CT scans performed in April 2006 show decreased tumor volume in liver (left) and pancreas (right).
Figure 4.
Figure 4.
February 2008 PET/CT scan showed a small lesion in the pancreas and a 1.8-cm lesion in the central part of the liver, but no evidence of hypermetabolic activity.
Figure 5.
Figure 5.
Histopathologic analysis of the pancreatic lesion specimens obtained in August 2008 reconfirmed the original diagnosis of pancreatic adenocarcinoma.
See this image and copyright information in PMC

References

    1. Gamelin L, Boisdron-Celle M, Delva R, et al. Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer. Clin Cancer Res. 2004;10:4055–4061. - PubMed
    1. Cascinu S, Catalano V, Cordella L, et al. Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2002;20:3478–3483. - PubMed
    1. Boyle F, Monk R, Davey R, et al. Prevention of experimental paclitaxel neuropathy with glutamine. Proc Am Assoc Can Res. 1996;37:290. (abstr 1974)
    1. Savarese DMF, Savy G, Vahdat L, et al. Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treat Rev. 2003;29:501–513. - PubMed
    1. Wang W-S, Lin J-K, Lin T-C, et al. Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients. The Oncologist. 2007;12:312–331. - PubMed

Publication types

LinkOut - more resources